Why is QMS Medical falling/rising?

As of 07-Jul, QMS Medical Allied Services Ltd is experiencing a price increase, currently at 83.35, reflecting a change of 5.6 or 7.2% upward. Today's price summary indicates that the stock has outperformed its sector by 8.29%, although it is trading higher than its 5-day moving averages but lower than its 20-day, 50-day, 100-day, and 200-day moving averages. Despite a significant decline in investor participation, with delivery volume dropping by 28.57% against the 5-day average, the company has reported positive financial results, including a highest quarterly PBDIT of Rs 7.83 crore and a 41.3% growth in PBT. The stock is also trading at a discount compared to its peers, which, combined with a PEG ratio of 0.9, suggests an attractive valuation despite its year-to-date decline of 26.53%.
In the broader market context, QMS Medical's short-term performance has been relatively strong, with a 1-week return of 0.79% compared to a slight decline of 0.22% in the Sensex. However, over the longer term, the stock has underperformed significantly, with a year-to-date drop of 26.53% against a 7.68% gain in the benchmark index. This contrast highlights the challenges the company faces despite recent positive financial indicators, as the overall market sentiment remains more favorable than that of QMS Medical.